185
Participants
Start Date
February 2, 2012
Primary Completion Date
August 20, 2015
Study Completion Date
August 20, 2015
Placebo
iv Days 1 and 8, and every 2 weeks thereafter
GC33
1600 mg iv Day 1 and 8, and every 2 weeks thereafter
Auckland Hospital; New Zealand Liver Transplant Unit, Auckland
National Taiwan Uni Hospital; Dept of Oncology, Taipei
Taipei Veterans General Hospital, Taipei
Hospital Erasme, Brussels
UZ Gent, Ghent
Columbia University Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
National Cancer Center, Gyeonggi-do
Charité Uni.-medizin Berlin, Campus Virchow-Klinikum; Med. Klinik m.S. Hepatologie Gastroenterologie, Berlin
Aphm; Hopital De La Conception, Marseille
Fondazione IRCCS Ospedale Maggiore Policlinico; Gastroenterologia, Milan
Hospital General Universitario Gregorio Marañon; Servicio de Oncologia, Madrid
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Universitario Clínico San Carlos; Servicio de Oncologia, Madrid
Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid
Hopital Purpan;Gastro Enterologie Hepatologie, Toulouse
Hospital Universitario Marques de Valdecilla; Servicio de Oncologia, Santander
Taichung Veterans Gen Hosp, Taichung
Barbara Ann Karmanos Cancer Institute, Detroit
Hotel Dieu; Medecine A, Angers
Hospital Universitario Miguel Servet; Servicio Hematologia, Zaragoza
Hôpital d'Adultes; Service hépato-gastro-entérologie, Vandœuvre-lès-Nancy
Klinik Johann Wolfgang von Goethe Uni; Zentrum der Inneren Medizin; Medizinische Klinik I, Frankfurt am Main
Washington Univ School of Med; Barnes-Jewish Hospital; Siteman Cancer Center, St Louis
Uni Heidelberg Med. Klinik; Innere Medizin IV, Heidelberg
Hôpital Saint Antoine; Service Hépathologie, Paris
Klinikum rechts der Isar der TU München; Klinikapotheke, München
Azienda Ospedaliera G. Rummo; Unità Operativa di Oncologia Medica 1, Benevento
UCLA Medical Center, Los Angeles
Swedish Cancer Inst., Seattle
National Cancer Centre; Medical Oncology, Singapore
National Cancer Institute; Ctr for Cancer Research, Bethesda
Vanderbilt Medical Center, Nashville
CHU de GRENOBLE; UF de Cancérologie, Grenoble
Hopital de L'Archet; Pole de Reference Hepatite C, Nice
Universitätsklinikum Leipzig, Leipzig
Queen Mary Hospital; Dept of Surgery, Pokfulam
Prince of Wales Hosp; Dept. Of Clinical Onc, Shatin
Policlinico Universitario Agostino Gemelli, Rome
National Cancer Center Hospital East, Chiba
Kanazawa University Hospital, Ishikawa
Kanagawa Cancer Center, Kanagawa
Kindai University Hospital, Osaka
National Cancer Center Hospital, Tokyo
Kyorin University Hospital, Tokyo
Pusan University Hospital, Busan
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Seoul St Mary's Hospital, Seoul
Hospital Universitari Vall d'Hebron; Servicio de Hepatologia, Barcelona
Hospital Clínic i Provincial; Servicio de Hematología y Oncología, Barcelona
Chang Gung Memorial Foundation - Kaohsiung, Kaohsiung City
National Cheng Kung Univ Hosp, Tainan City
The Clatterbridge Cancer Ctr NHS Foundation Trust, Bebington
Royal Free Hospital; Dept of Oncology, London
King'S College Hospital; Haematology, London
Hoffmann-La Roche
INDUSTRY